NEUMORA THERAPEUTICS INC (NMRA)

US6409791000 - Common Stock

2.48  +0.31 (+14.29%)

Premarket: 2.49 +0.01 (+0.4%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
250.64M188.19M122.87M80.32M25.50M
Research and Development
193.88M142.72M91.75M55.78M17.11M
Selling, General, and Administrative Expenses
56.76M45.48M31.12M24.55M8.39M
Operating Income
-250.64M-188.19M-122.87M-80.32M-25.50M
Interest Income/Expense
21.49M16.61M4.56M0.00N/A
Other Income/Expense
-197.00K-170.00K410.00K10.00K-80.00K
Non Recurring Items
N/A-63.90M-13.00M-157.00M-73.69M
Income Before Taxes
-293.25M-235.66M-130.90M-237.31M-99.27M
Income Tax
N/A268.00KN/AN/AN/A
Net Income
-293.70M-235.93M-130.90M-237.31M-99.27M
EBITDA
-250.00M-187.53M-122.28M-79.78M-25.39M
 
Per Share Data
EPS Diluted Total Ops
-1.77-1.49-0.86-1.56-0.65
Non GAAP EPS
-1.87N/AN/AN/AN/A
 
Statistics

All data in USD

Charts